Logo

Indications - This is indicated in-  Long-term, once-daily, maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD).  Once-daily treatment of asthma in patients aged 18 years and older. Important limitation of use: Not indicated for relief of acute bronchospasm.

Dosage & Administration - This inhalation capsule must not be swallowed. Only to be used with the device. Remove the capsule from the blister pack only immediately before using it in the inhalation device. After inhalation, rinse your mouth with water without swallowing to reduce the risk of oropharyngeal candidiasis.

Side Effects - COPD: Most common adverse reactions (incidence ≥3%) are nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, back pain, pneumonia, bronchitis, sinusitis, cough, oropharyngeal pain, arthralgia, hypertension, influenza, pharyngitis, and pyrexia. Asthma: Most common adverse reactions (incidence ≥2%) are nasopharyngitis, oral candidiasis, headache, influenza, upper respiratory tract infection, bronchitis, sinusitis, oropharyngeal pain, dysphonia, and cough.

Contraindications -  Primary treatment of status asthmaticus or acute episodes of COPD or asthma requiring intensive measures.  Severe hypersensitivity to milk proteins or any ingredients.

Others - Pregnancy & Lactation : Insufficient data on the use of this preparation in pregnant women and lactating mother.